Murray Passo to Adolescent
This is a "connection" page, showing publications Murray Passo has written about Adolescent.
Connection Strength
0.506
-
Differences in disease outcomes between medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis. Arthritis Rheum. 2006 Jun 15; 55(3):378-84.
Score: 0.027
-
Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus. 2006; 15(4):198-206.
Score: 0.026
-
Social, emotional, and behavioral functioning of children with juvenile rheumatoid arthritis. Arthritis Rheum. 2000 Jun; 43(6):1387-96.
Score: 0.018
-
Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med. 2000 May; 154(5):478-83.
Score: 0.018
-
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
Score: 0.016
-
The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1999 Jan; 134(1):47-52.
Score: 0.016
-
Use of methotrexate in children. Bull Rheum Dis. 1998 Aug; 47(5):1-5.
Score: 0.016
-
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
Score: 0.016
-
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy. Arthritis Rheumatol. 2018 04; 70(4):594-605.
Score: 0.015
-
The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1997 Dec; 40(12):2226-34.
Score: 0.015
-
Magnetic resonance imaging in juvenile rheumatoid arthritis. Semin Arthritis Rheum. 1997 Dec; 27(3):161-8.
Score: 0.015
-
Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia. Pain. 2014 Jul; 155(7):1206-1212.
Score: 0.012
-
Utility of the PedsQL rheumatology module as an outcome measure in juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2013 Nov; 65(11):1820-7.
Score: 0.011
-
Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 May; 65(5):745-52.
Score: 0.011
-
Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. J Pain. 2013 May; 14(5):492-501.
Score: 0.011
-
Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012 Jan; 64(1):297-305.
Score: 0.010
-
Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011 Nov; 63(11):1511-6.
Score: 0.010
-
Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford). 2010 Nov; 49(11):2204-9.
Score: 0.009
-
Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain. 2010 Sep; 11(9):885-93.
Score: 0.009
-
Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J Pediatr Psychol. 2010 Oct; 35(9):996-1004.
Score: 0.009
-
Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009 Sep; 60(9):2772-81.
Score: 0.008
-
Educational and occupational outcomes among young adults with juvenile idiopathic arthritis. Arthritis Rheum. 2008 Oct 15; 59(10):1385-91.
Score: 0.008
-
Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008 Sep; 24(7):620-6.
Score: 0.008
-
Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008 Mar; 23(3):403-12.
Score: 0.008
-
Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2007 Oct 15; 57(7):1174-82.
Score: 0.007
-
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007 Mar; 56(3):965-71.
Score: 0.007
-
Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006 Aug; 54(8):2577-84.
Score: 0.007
-
A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2006 Jul; 54(7):2235-42.
Score: 0.007
-
Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986 May; 31(5):492-7.
Score: 0.007
-
What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Clin Exp Rheumatol. 2006 May-Jun; 24(3):333-43.
Score: 0.007
-
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2005 Aug 15; 53(4):565-70.
Score: 0.006
-
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. J Clin Rheumatol. 2005 Aug; 11(4):194-204.
Score: 0.006
-
Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2005 Jan; 52(1):239-46.
Score: 0.006
-
Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects. Vaccine. 2004 Dec 16; 23(5):687-92.
Score: 0.006
-
Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis. Arthritis Rheum. 2004 Dec 15; 51(6):899-908.
Score: 0.006
-
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005; 7(1):R30-7.
Score: 0.006
-
Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum. 2004 Oct 15; 51(5):763-73.
Score: 0.006
-
Idiopathic hypercalcemia and eosinophilic fasciitis: a novel association. J Pediatr Endocrinol Metab. 2004 Sep; 17(9):1251-4.
Score: 0.006
-
Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritis. Rheumatology (Oxford). 2004 Aug; 43(8):973-9.
Score: 0.006
-
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2004 May; 50(5):1595-603.
Score: 0.006
-
Subcutaneous panniculitic T-cell lymphoma in children: response to combination therapy with cyclosporine and chemotherapy. J Am Acad Dermatol. 2004 Feb; 50(2 Suppl):S18-22.
Score: 0.006
-
Brief report: child-rearing practices of caregivers with and without a child with juvenile rheumatoid arthritis: perspectives of caregivers and professionals. J Pediatr Psychol. 2003 Jun; 28(4):275-9.
Score: 0.006
-
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003 Mar; 142(3):292-6.
Score: 0.005
-
Comparing parental distress, family functioning, and the role of social support for caregivers with and without a child with juvenile rheumatoid arthritis. J Pediatr Psychol. 2003 Jan-Feb; 28(1):5-15.
Score: 0.005
-
A controlled longitudinal study of the social functioning of children with juvenile rheumatoid arthritis. J Pediatr Psychol. 2003 Jan-Feb; 28(1):17-28.
Score: 0.005
-
Aches and limb pain. Pediatr Clin North Am. 1982 Feb; 29(1):209-19.
Score: 0.005
-
Arthritis in childhood. J Indiana State Med Assoc. 1981 Sep; 74(9):559-64.
Score: 0.005
-
Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001 Jun 01; 166(11):6899-906.
Score: 0.005
-
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol. 2001 May; 28(5):1106-11.
Score: 0.005
-
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum. 1999 Oct; 42(10):2213-9.
Score: 0.004
-
An adolescent with nephrotic syndrome and multiple leg nodules. Pediatr Infect Dis J. 1998 Nov; 17(11):1057-8, 1061-3.
Score: 0.004
-
Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res. 1998 Oct; 11(5):391-6.
Score: 0.004
-
Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol. 1998 Jul; 25(7):1388-98.
Score: 0.004
-
Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol. 1996 Dec; 23(12):2116-24.
Score: 0.004
-
Long term follow-up of children with mixed connective tissue disease. Lupus. 1996 Jun; 5(3):221-6.
Score: 0.003
-
Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1994 Dec; 21(12):2353-8.
Score: 0.003
-
Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991 Sep; 18(9):1394-7.
Score: 0.002
-
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr. 1990 Oct; 117(4):645-52.
Score: 0.002
-
Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyositis/dermatomyositis. Arthritis Rheum. 1989 Apr; 32(4):446-53.
Score: 0.002
-
School problems and teacher responsibilities in juvenile rheumatoid arthritis. J Sch Health. 1987 May; 57(5):186-90.
Score: 0.002